1689 related articles for article (PubMed ID: 25198809)
1. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
2. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
Moss JG; Wu O; Bodenham AR; Agarwal R; Menne TF; Jones BL; Heggie R; Hill S; Dixon-Hughes J; Soulis E; Germeni E; Dillon S; McCartney E;
Lancet; 2021 Jul; 398(10298):403-415. PubMed ID: 34297997
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
5. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days.
Kang J; Chen W; Sun W; Ge R; Li H; Ma E; Su Q; Cheng F; Hong J; Zhang Y; Lei C; Wang X; Jin A; Liu W
J Vasc Access; 2017 Mar; 18(2):153-157. PubMed ID: 28218366
[TBL] [Abstract][Full Text] [Related]
6. Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures.
Bertoglio S; Faccini B; Lalli L; Cafiero F; Bruzzi P
J Surg Oncol; 2016 May; 113(6):708-14. PubMed ID: 27020965
[TBL] [Abstract][Full Text] [Related]
7. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of PICC complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy.
Valbousquet Schneider L; Duron S; Arnaud FX; Bousquet A; Kervella Y; Bouzad C; Baccialone J; A'Teriitehau C; Potet J
J Vasc Access; 2015; 16(4):299-308. PubMed ID: 25953205
[TBL] [Abstract][Full Text] [Related]
9. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
10. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
Patel GS; Jain K; Kumar R; Strickland AH; Pellegrini L; Slavotinek J; Eaton M; McLeay W; Price T; Ly M; Ullah S; Koczwara B; Kichenadasse G; Karapetis CS
Support Care Cancer; 2014 Jan; 22(1):121-8. PubMed ID: 24005884
[TBL] [Abstract][Full Text] [Related]
11. Peripherally inserted central catheters versus non-tunnelled ultrasound-guided central venous catheters in newborns: a retrospective observational study.
Bayoumi MAA; van Rens R; Chandra P; Shaltout D; Gad A; Elmalik EE; Hammoudeh S
BMJ Open; 2022 Apr; 12(4):e058866. PubMed ID: 35387831
[TBL] [Abstract][Full Text] [Related]
12. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
Wu O; McCartney E; Heggie R; Germeni E; Paul J; Soulis E; Dillon S; Ryan C; Sim M; Dixon-Hughes J; Agarwal R; Bodenham A; Menne T; Jones B; Moss J
Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
[TBL] [Abstract][Full Text] [Related]
13. Repurposing the power injectable peripherally inserted central catheter as a tunnelled, non-cuffed, centrally inserted central venous catheter in oncological patients for short- to mid-term vascular access: A pilot study.
Low XZ; Tay KH; Leong S; Lo RHG; Zhuang KD; Chua JME; Too CW
J Vasc Access; 2021 May; 22(3):457-461. PubMed ID: 32715861
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized comparison of three different types of valved and non-valved peripherally inserted central catheters.
Pittiruti M; Emoli A; Porta P; Marche B; DeAngelis R; Scoppettuolo G
J Vasc Access; 2014; 15(6):519-23. PubMed ID: 25198813
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two types of catheters through femoral vein catheterization in patients with lung cancer undergoing chemotherapy: A retrospective study.
Xu B; Zhang J; Tang S; Hou J; Ma M
J Vasc Access; 2018 Nov; 19(6):651-657. PubMed ID: 29701120
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of peripherally inserted central venous catheters in acute cardiac care management.
Poletti F; Coccino C; Monolo D; Crespi P; Ciccioli G; Cordio G; Seveso G; De Servi S
J Vasc Access; 2018 Sep; 19(5):455-460. PubMed ID: 29514546
[TBL] [Abstract][Full Text] [Related]
17. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study.
Rykov MY; Zaborovskij SV; Shvecov AN; Shukin VV
J Vasc Access; 2018 Jul; 19(4):378-381. PubMed ID: 29546772
[TBL] [Abstract][Full Text] [Related]
18. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
19. Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.
Solinas G; Platini F; Trivellato M; Rigo C; Alabiso O; Galetto AS
J Vasc Access; 2017 Jul; 18(4):325-327. PubMed ID: 28665463
[TBL] [Abstract][Full Text] [Related]
20. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
